Second Sight Medical Products- Warrants (14/03/2024) Current Cash

As of the most recent data (June 2026), EYESW shows a current cash of $20M. That compares with $6.8M in the prior-year period — up 192.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EYESW's current cash is now $20M (was $6.8M) — a 192.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Second Sight Medical Products- Warrants (14/03/2024) is outperforming or lagging.

Tracking EYESW's current cash over time shows whether Second Sight Medical Products- Warrants (14/03/2024) is scaling, shrinking, or reshaping that part of the business. The current reading is $20M That compares with $6.8M in the prior-year period — up 192.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Second Sight Medical Products- Warrants (14/03/2024)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $20M) with ownership activity and broader fundamentals.

Second Sight Medical Products- Warrants (14/03/2024)'s current cash is $20M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.